Accuray Incorporated (ARAY) - Net Assets
Based on the latest financial reports, Accuray Incorporated (ARAY) has net assets worth $41.70 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($443.68 Million) and total liabilities ($401.98 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset allocation strategy of Accuray Incorporated to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $41.70 Million |
| % of Total Assets | 9.4% |
| Annual Growth Rate | N/A |
| 5-Year Change | -21.6% |
| 10-Year Change | -10.39% |
| Growth Volatility | 29.5 |
Accuray Incorporated - Net Assets Trend (2002–2026)
This chart illustrates how Accuray Incorporated's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see ARAY market cap overview.
Annual Net Assets for Accuray Incorporated (2002–2026)
The table below shows the annual net assets of Accuray Incorporated from 2002 to 2026. Also explore ARAY shareholders equity momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-06-30 | $41.70 Million | -48.63% |
| 2025-06-30 | $81.17 Million | +80.04% |
| 2024-06-30 | $45.08 Million | -15.98% |
| 2023-06-30 | $53.66 Million | +0.88% |
| 2022-06-30 | $53.19 Million | -22.74% |
| 2021-06-30 | $68.84 Million | +8.18% |
| 2020-06-30 | $63.63 Million | +27.60% |
| 2019-06-30 | $49.87 Million | +2.55% |
| 2018-06-30 | $48.63 Million | +4.51% |
| 2017-06-30 | $46.53 Million | -22.00% |
| 2016-06-30 | $59.66 Million | -21.27% |
| 2015-06-30 | $75.78 Million | -23.10% |
| 2014-06-30 | $98.55 Million | -7.76% |
| 2013-06-30 | $106.83 Million | -47.60% |
| 2012-06-30 | $203.87 Million | -15.17% |
| 2011-06-30 | $240.33 Million | +41.31% |
| 2010-06-30 | $170.08 Million | +10.51% |
| 2009-06-30 | $153.90 Million | +17.70% |
| 2008-06-30 | $130.76 Million | +4.24% |
| 2007-06-30 | $125.44 Million | +255.15% |
| 2006-06-30 | $-80.86 Million | -43.94% |
| 2005-06-30 | $-56.17 Million | -69.97% |
| 2003-06-30 | $-33.05 Million | -39.84% |
| 2002-06-30 | $-23.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Accuray Incorporated's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 56846600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $119.00K | 0.29% |
| Other Comprehensive Income | $-3.51 Million | -8.42% |
| Other Components | $613.56 Million | 1471.40% |
| Total Equity | $41.70 Million | 100.00% |
Accuray Incorporated Competitors by Market Cap
The table below lists competitors of Accuray Incorporated ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Riverstone Credit Opportunities Income Plc
LSE:RCOI
|
$28.81 Million |
|
HarbourVest Global Private Equity Ltd
LSE:HVPE
|
$28.81 Million |
|
Uvre Ltd
AU:UVA
|
$28.85 Million |
|
Bellway PLC
LSE:BWY
|
$28.86 Million |
|
Franklin Wireless Corp
NASDAQ:FKWL
|
$28.75 Million |
|
Financiere Marjos SA
PA:FINM
|
$28.75 Million |
|
Kyntra Bio, Inc.
NASDAQ:KYNB
|
$28.74 Million |
|
IDENTILLECT TECHN. O.N.
F:8ID
|
$28.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Accuray Incorporated's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 81,169,000 to 41,699,000, a change of -39,470,000 (-48.6%).
- Net loss of 49,194,000 reduced equity.
- New share issuances of 665,000 increased equity.
- Other comprehensive income decreased equity by 1,676,000.
- Other factors increased equity by 10,735,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-49.19 Million | -117.97% |
| Share Issuances | $665.00K | +1.59% |
| Other Comprehensive Income | $-1.68 Million | -4.02% |
| Other Changes | $10.73 Million | +25.74% |
| Total Change | $- | -48.63% |
Book Value vs Market Value Analysis
This analysis compares Accuray Incorporated's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.71x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-06-30 | $-2.24 | $0.24 | x |
| 2003-06-30 | $-3.12 | $0.24 | x |
| 2005-06-30 | $-3.93 | $0.24 | x |
| 2006-06-30 | $-5.05 | $0.24 | x |
| 2007-06-30 | $4.08 | $0.24 | x |
| 2008-06-30 | $2.16 | $0.24 | x |
| 2009-06-30 | $2.62 | $0.24 | x |
| 2010-06-30 | $2.83 | $0.24 | x |
| 2011-06-30 | $3.82 | $0.24 | x |
| 2012-06-30 | $2.76 | $0.24 | x |
| 2013-06-30 | $1.46 | $0.24 | x |
| 2014-06-30 | $1.30 | $0.24 | x |
| 2015-06-30 | $0.97 | $0.24 | x |
| 2016-06-30 | $0.74 | $0.24 | x |
| 2017-06-30 | $0.56 | $0.24 | x |
| 2018-06-30 | $0.57 | $0.24 | x |
| 2019-06-30 | $0.57 | $0.24 | x |
| 2020-06-30 | $0.70 | $0.24 | x |
| 2021-06-30 | $0.75 | $0.24 | x |
| 2022-06-30 | $0.58 | $0.24 | x |
| 2023-06-30 | $0.57 | $0.24 | x |
| 2024-06-30 | $0.46 | $0.24 | x |
| 2025-06-30 | $0.79 | $0.24 | x |
| 2026-06-30 | $0.34 | $0.24 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Accuray Incorporated utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -117.97%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -12.24%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 10.64x
- Recent ROE (-117.97%) is below the historical average (-25.24%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | -29.95% | 1.62x | 0.00x | $-3.43 Million |
| 2003 | 0.00% | -584.50% | 0.08x | 0.00x | $-12.54 Million |
| 2005 | 0.00% | -112.57% | 0.26x | 0.00x | $-19.57 Million |
| 2006 | 0.00% | -63.70% | 0.38x | 0.00x | $-25.61 Million |
| 2007 | -4.48% | -4.00% | 0.42x | 2.65x | $-18.16 Million |
| 2008 | 4.12% | 2.56% | 0.71x | 2.26x | $-7.69 Million |
| 2009 | 0.40% | 0.26% | 0.85x | 1.78x | $-14.78 Million |
| 2010 | 1.67% | 1.28% | 0.84x | 1.55x | $-14.17 Million |
| 2011 | -11.61% | -12.00% | 0.49x | 1.98x | $-49.66 Million |
| 2012 | -36.83% | -17.60% | 0.86x | 2.42x | $-91.60 Million |
| 2013 | -96.62% | -32.67% | 0.66x | 4.45x | $-113.90 Million |
| 2014 | -35.97% | -9.60% | 0.75x | 5.02x | $-45.30 Million |
| 2015 | -53.06% | -10.59% | 0.81x | 6.20x | $-47.79 Million |
| 2016 | -42.75% | -6.40% | 0.85x | 7.86x | $-31.47 Million |
| 2017 | -63.57% | -7.71% | 0.94x | 8.73x | $-34.23 Million |
| 2018 | -49.14% | -5.90% | 1.07x | 7.79x | $-28.76 Million |
| 2019 | -32.94% | -3.92% | 0.96x | 8.79x | $-21.42 Million |
| 2020 | 6.01% | 1.00% | 0.78x | 7.71x | $-2.54 Million |
| 2021 | -9.17% | -1.59% | 0.83x | 6.97x | $-13.20 Million |
| 2022 | -10.05% | -1.24% | 0.91x | 8.89x | $-10.67 Million |
| 2023 | -17.29% | -2.07% | 0.93x | 8.93x | $-14.65 Million |
| 2024 | -34.48% | -3.48% | 0.95x | 10.39x | $-20.05 Million |
| 2025 | -1.96% | -0.35% | 0.98x | 5.79x | $-9.71 Million |
| 2026 | -117.97% | -12.24% | 0.91x | 10.64x | $-53.36 Million |
Industry Comparison
This section compares Accuray Incorporated's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $41.70 Million | 0.00% | 9.64x | $28.78 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About Accuray Incorporated
Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation t… Read more